Abstract
A review of the published literature on propoxyphene hydrochloride was undertaken to determine if the wide popularity of the drug is justified. Only double-blind studies were reviewed; 20 were identified in a bibliography of 243 articles. In the course of the review, deficiencies in the design, conduct, and reporting of the clinical studies were noted. The addiction liability of propoxyphene is low but several reports have demonstrated its abuse potential. The reviewed studies show that propoxyphene is not superior to codeine or aspirin in terms of analgesic effect. No definite statement as to relative incidence of side effects can be made. It appears that factors other than intrinsic therapeutic value are responsible for the commercial success of propoxyphene.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
